@misc{indiciae12e2820512c3,
  title = {Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.},
  author = {Tsuguo Iwatani and Norikazu Masuda and Shigehira Saji and Takuhiro Yamaguchi and Yasuyuki Kojima and Masahiro Kitada and Hiroshi Tada and Tsutomu Iwasa and Kei Koizumi and Hideo Shigematsu and Yasuaki Sagara and Toshitaka Okuno and Yoshie Hasegawa and Eriko Tokunaga and Tadahiko Shien and Uhi Toh and Hiroki Hasegawa and Shun Osaka and Satoshi Morita and Toshinari Yamashita},
  year = {2026},
  doi = {10.1007/s12282-026-01876-x},
  url = {https://pubmed.ncbi.nlm.nih.gov/42268523/},
  note = {Source identifier: 42268523}
}